ArticleJournal of experimental & clinical cancer research : CR2025

High-throughput drug screening in advanced pre-clinical 3D melanoma models identifies potential first-line therapies for NRAS-mutated melanoma.

Cristian Angeli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.